Views: 0 Author: Site Editor Publish Time: 2026-03-25 Origin: Site
Suzhou Genemill Biotechnology Co., Ltd. (Suzhou Genemill), a leading provider of high-quality raw materials for the in vitro diagnostic (IVD) industry, is proud to participate in the 23rd China International Conference on Laboratory Medicine and Blood Transfusion Instruments & Reagents Expo (CACLP 2026) and the 6th China International IVD Upstream Materials & Supply Chain Expo held from March 21 to 23 at the Xiamen International Expo Center.
As a exhibitor at this important global IVD industry event, we showcased our core product portfolio, including the proprietary NeoCide® series of preservatives, high-purity biological buffers (Tris, HEPES, MOPS, PIPES, etc.), and customized raw material solutions tailored for IVD diagnostic reagents. These products are widely applied in immunoassay, biochemical diagnosis, molecular diagnosis, microbial diagnosis, and blood diagnosis, addressing the industry’s demand for stable, safe, and high-compatibility raw materials.
At CACLP 2026, we engaged in in-depth technical exchanges and business negotiations with global IVD manufacturers, research institutions, and industry partners. By demonstrating our R&D capabilities, quality control systems, and supply chain advantages, we stand as a trusted supplier of upstream raw materials for the global IVD industry.
"CACLP serves as a vital platform for technological innovation and industry collaboration," said Leo Xie, Technical Sales Manager of Suzhou Genemill. "We are committed to providing reliable, cost-effective raw material solutions to empower the development of the IVD industry and contribute to the improvement of global medical diagnostics."